BioTech

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A...

Inolex has announced it is to develop its US manufacturing facilities, with the new expansion set to replace the company’s current US production and warehouse operations. The expansion is set for completion in the second half of 2019 with a new flagship plant in Charlotte, North Carolina. David Plimpton, Inolex CEO, says, “This is a...

Source: globenewswire.com Columbia based, Osiris Therapeutics (NASDAQ: OSIR), is engaged in the research, development, and manufacturing of regenerative medicine products intended to improve the health...

Spark Therapeutics (ONCE), a commercial gene therapy company, announced Friday that the European Commission has granted marketing authorization for LUXTURNA (voretigene neparvovec).

MARLBOROUGH, Mass., Nov. 20, 2018 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced it has reached an agreement on the terms of a recommended offe

EAST HANOVER, N.J., Nov. 16, 2018 /PRNewswire/ -- Novartis announced today that the US Food and Drug Administration (FDA) has expanded the label fo

PharmaCyte Biotech announces publication of U.S. patent application for cancer therapies.

Sobi™ to Acquire Synagis® US Rights From AstraZeneca - Creates a Platform for Global Growth - read this article along with other careers information, tips and advice on BioSpace

Biggest News Source for News in Uganda and the East African Region ,Breaking news in Uganda and Daily news and the latest from Uganda

NORTH CHICAGO, Ill., Nov. 1, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, announced today that th